[Stability control of a copper histidinate solution].
Some authors have suggested the administration subcutaneous of copper histidinate for the treatment of the Menkes disease. The purpose of this study was to control the complex formation of Cu (II)-L-Histidine in molar ratio 1/2 and to verify the stability in some conditions of determination and validation production.
Leclercq
V
V
Pharmacie centrale, CHRU de Lille.
Torck
M
M
Guislain
B
B
D003300:Copper / Q000008:administration & dosage*; D004338:Drug Combinations; D004355:Drug Stability; D006639:Histidine / Q000008:administration & dosage*; D066298:In Vitro Techniques; D012996:Solutions
D004338:Drug Combinations; D012996:Solutions; D006639:Histidine; D003300:Copper
Contrôle de la stabilité d'une solution d'histidinate de cuivre.